TUESDAY, Nov. 23, 2021 (HealthDay News) — Seniors, looking for a way to stay mentally quick and physically strong? Start scrubbing. Researchers from Singapore say housework may be a key to keeping your brain sharp as you age. Their new study found that in older adults, cleaning house was tiedContinue Reading
TUESDAY, Nov. 23, 2021 (HealthDay News) — Teens and young adults with autism show marked differences in their brains’ white matter compared to those without the disorder, a new study finds. “If you think of gray matter as the computer, white matter is like the cables,” said study co-author ClaraContinue Reading
MONDAY, Nov. 22, 2021 (HealthDay News) — Physiotherapist David Putrino was working on a vibrating glove to help deaf people experience live music when a friend mentioned that the same technology might stop tremors in people with Parkinson’s disease. Putrino, director of rehabilitation innovation for Mount Sinai Health System inContinue Reading
MONDAY, Nov. 22, 2021 (HealthDay News) — Most prescriptions for the medication gabapentin are for unapproved uses — and many patients end up taking it along with drugs that create potentially dangerous interactions. That’s the conclusion of a new study that looked at “off-label” use of gabapentin. In the UnitedContinue Reading
MONDAY, Nov. 22, 2021 (HealthDay News) — Tight blood pressure control — not too high and not too low — during surgery for spinal cord injuries may improve patients’ outcomes, a new study suggests. “Damage to neurons in spinal cord injuries leads to dysregulation of blood pressure, which in turnContinue Reading
FRIDAY, Nov. 19, 2021 (HealthDay News) — Guidelines for treating movement problems in people in the early stages of Parkinson’s disease have been updated. The new treatment recommendations from the American Academy of Neurology (AAN) focus on dopaminergic medications, which increase dopamine levels or mimic dopamine effects. Parkinson’s is aContinue Reading
THURSDAY, Nov. 18, 2021 (HealthDay News) — Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines. “Aducanumab is not a cure for Alzheimer’s disease,Continue Reading
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — Claire Wiedmaier experiences epileptic seizures so bad that she’s broken teeth while in their grip. “I have some fake teeth. I broke my two bottom front teeth,” said Wiedmaier, 23, of Ankeny, Iowa, who these days can expect to have at least fourContinue Reading
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research. This is a “remarkable milestone,” according to Dr. Howard Weiner, co-director of the Ann Romney Center forContinue Reading
MONDAY, Nov. 15, 2021 (HealthDay News) — A new and expensive Alzheimer’s drug called Aduhelm is responsible for about half of the $21.60 increase in monthly premiums for Medicare’s Part B outpatient program in 2022, Medicare officials report. The new premium will be $170.10 a month, and the $21.60 boostContinue Reading